Connor, Clark & Lunn Investment Management Ltd. Avanos Medical, Inc. Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $18.8 Billion
- Q3 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 45,668 shares of AVNS stock, worth $810,607. This represents 0.01% of its overall portfolio holdings.
Number of Shares
45,668
Previous 28,739
58.91%
Holding current value
$810,607
Previous $572,000
91.78%
% of portfolio
0.01%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding AVNS
# of Institutions
275Shares Held
42.5MCall Options Held
5.4KPut Options Held
5K-
Black Rock Inc. New York, NY7.01MShares$124 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.32MShares$94.4 Million0.0% of portfolio
-
Rgm Capital, LLC Naples, FL3.17MShares$56.3 Million3.28% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.59MShares$46 Million0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.37MShares$42 Million0.03% of portfolio
About AVANOS MEDICAL, INC.
- Ticker AVNS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 46,487,000
- Market Cap $825M
- Description
- Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...